Learn how CYP450 genetics, phase 2 metabolism, and drug interactions shape psychiatric dosing—what’s actionable now and what’s next in PPGx.
Abby Ao, DO
Advertisement
Dr Ao is a first-year psychiatry resident in the Kaiser Oakland Psychiatry Residency Program and a graduate of Touro University California College of Osteopathic Medicine.
Articles by Abby Ao, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder
2
FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults
3
How Can Sleep Disruption Trigger Mood Episodes?
4
Evaluating Transdermal Asenapine in Schizophrenia
5